Novavax Says U.S. Will Pause Funding for Production of Its Vaccine

WASHINGTON — Novavax, the Maryland firm that won a $1.75 billion federal contract to develop and produce a coronavirus vaccine, said on Thursday that the federal government would not fund further production of its vaccine until the company resolves concerns of federal regulators about its work. The …

Read more

Show More

Related Articles

Back to top button